6.
Michalska P, Leon R
. When It Comes to an End: Oxidative Stress Crosstalk with Protein Aggregation and Neuroinflammation Induce Neurodegeneration. Antioxidants (Basel). 2020; 9(8).
PMC: 7463521.
DOI: 10.3390/antiox9080740.
View
7.
Freer R, Sormanni P, Vecchi G, Ciryam P, Dobson C, Vendruscolo M
. A protein homeostasis signature in healthy brains recapitulates tissue vulnerability to Alzheimer's disease. Sci Adv. 2016; 2(8):e1600947.
PMC: 4980108.
DOI: 10.1126/sciadv.1600947.
View
8.
Rovelet-Lecrux A, Hannequin D, Raux G, Le Meur N, Laquerriere A, Vital A
. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet. 2005; 38(1):24-6.
DOI: 10.1038/ng1718.
View
9.
Singleton A, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J
. alpha-Synuclein locus triplication causes Parkinson's disease. Science. 2003; 302(5646):841.
DOI: 10.1126/science.1090278.
View
10.
Wallon D, Boluda S, Rovelet-Lecrux A, Thierry M, Lagarde J, Miguel L
. Clinical and neuropathological diversity of tauopathy in MAPT duplication carriers. Acta Neuropathol. 2021; 142(2):259-278.
DOI: 10.1007/s00401-021-02320-4.
View
11.
Farrer M, Maraganore D, Lockhart P, Singleton A, Lesnick T, de Andrade M
. alpha-Synuclein gene haplotypes are associated with Parkinson's disease. Hum Mol Genet. 2001; 10(17):1847-51.
DOI: 10.1093/hmg/10.17.1847.
View
12.
Singleton A, Myers A, Hardy J
. The law of mass action applied to neurodegenerative disease: a hypothesis concerning the etiology and pathogenesis of complex diseases. Hum Mol Genet. 2004; 13 Spec No 1:R123-6.
DOI: 10.1093/hmg/ddh093.
View
13.
Potter R, Patterson B, Elbert D, Ovod V, Kasten T, Sigurdson W
. Increased in vivo amyloid-β42 production, exchange, and loss in presenilin mutation carriers. Sci Transl Med. 2013; 5(189):189ra77.
PMC: 3838868.
DOI: 10.1126/scitranslmed.3005615.
View
14.
Mawuenyega K, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris J
. Decreased clearance of CNS beta-amyloid in Alzheimer's disease. Science. 2010; 330(6012):1774.
PMC: 3073454.
DOI: 10.1126/science.1197623.
View
15.
Fan X, Wheatley E, Villeda S
. Mechanisms of Hippocampal Aging and the Potential for Rejuvenation. Annu Rev Neurosci. 2017; 40:251-272.
DOI: 10.1146/annurev-neuro-072116-031357.
View
16.
Streit W
. Microglial senescence: does the brain's immune system have an expiration date?. Trends Neurosci. 2006; 29(9):506-10.
DOI: 10.1016/j.tins.2006.07.001.
View
17.
Spina S, La Joie R, Petersen C, Nolan A, Cuevas D, Cosme C
. Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease. Brain. 2021; 144(7):2186-2198.
PMC: 8502474.
DOI: 10.1093/brain/awab099.
View
18.
Forman M, Schmidt M, Kasturi S, Perl D, Lee V, Trojanowski J
. Tau and alpha-synuclein pathology in amygdala of Parkinsonism-dementia complex patients of Guam. Am J Pathol. 2002; 160(5):1725-31.
PMC: 1850878.
DOI: 10.1016/s0002-9440(10)61119-4.
View
19.
Attems J, Jellinger K
. The overlap between vascular disease and Alzheimer's disease--lessons from pathology. BMC Med. 2014; 12:206.
PMC: 4226890.
DOI: 10.1186/s12916-014-0206-2.
View
20.
Farfel J, Capuano A, Buchman A, Schneider J, Bennett D
. Association of Alzheimer's Disease and Other Neuropathologies With Functional Disability in Persons With and Without Dementia. J Gerontol A Biol Sci Med Sci. 2024; 79(9).
PMC: 11350283.
DOI: 10.1093/gerona/glae118.
View